.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chubb
AstraZeneca
QuintilesIMS
Citi
Express Scripts
Baxter
Queensland Health
Federal Trade Commission
Fuji

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020901

« Back to Dashboard

NDA 020901 describes METROLOTION, which is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from two suppliers. Additional details are available on the METROLOTION profile page.

The generic ingredient in METROLOTION is metronidazole. There are eighteen drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

Summary for 020901

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 020901

Ingredient-typeNitroimidazoles

Medical Subject Heading (MeSH) Categories for 020901

Suppliers and Packaging for NDA: 020901

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METROLOTION metronidazole LOTION;TOPICAL 020901 NDA Galderma Laboratories, L.P. 0299-3838 0299-3838-02 1 BOTTLE, PLASTIC in 1 CARTON (0299-3838-02) > 59 mL in 1 BOTTLE, PLASTIC
METROLOTION metronidazole LOTION;TOPICAL 020901 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-961 66993-961-59 1 BOTTLE in 1 CARTON (66993-961-59) > 59.7 g in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.75%
Approval Date:Nov 24, 1998TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
Accenture
Covington
Baxter
Julphar
QuintilesIMS
Novartis
Federal Trade Commission
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot